Cancer Immunotherapy GSK1572932A as Adjuvant Therapy for Patients With Tumor-antigen-positive Non-Small Cell Lung Cancer

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT00455572
Recruitment Status : Terminated (Study early termination was due to slow recruitment and difficulties at achieving the required enrolment for the study.)
First Posted : April 3, 2007
Last Update Posted : May 15, 2017
Information provided by (Responsible Party):